Travere (TVTX) Soars 5.9%: Is Further Upside Left in the Stock?
TVTXTravere Therapeutics(TVTX) ZACKS·2024-09-17 21:40

Travere Therapeutics (TVTX) shares rallied 5.9% in the last trading session to close at 14.27.Thismovecanbeattributabletonotablevolumewithahighernumberofsharesbeingtradedthaninatypicalsession.Thiscomparestothestock′s55.314.27. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 55.3% gain over the past four weeks.The company markets Filspari (sparsentan), an oral non-immunosuppressive drug approved for treating IgA nephropathy (IgAN), a rare kidney disease. Filspari has seen strong market demand, generating 47 million in sales in the first ...